Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 12, 2011, Pages 2503-2506

  Dentali, F ^a   Grandone, E ^b   Rezoagli, E ^a   Ageno, W ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

CONFIDENCE INTERVAL; DRUG EFFICACY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; KAPPA STATISTICS; LETTER; LIVE BIRTH; MATERNAL AGE; MICROTHROMBUS; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; THROMBOPHILIA; TROPHOBLAST;

FEMALE; FERTILIZATION IN VITRO; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 82755187529     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04535.x     Document Type: Letter

References (19)

1. Nygren KG, Andersen AN. European IVF-monitoring programme (EIM). Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. European Society of Human Reproduction and Embryology. Hum Reprod 2001; 16: 2459-71.
2. Harlin J, Aanesen A, Csemiczky G, Wramsby H, Fried G. Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation. Hum Reprod 2002; 17: 304-9.
3. Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion - a cause of infertility. Hum Reprod 1988; 3: 955-9.
4. Groeneveld E, Broeze KA, Lambers MJ, Haapsamo M, Dirckx K, Schoot BC, Salle B, Duvan CI, Schats R, Mol BW, Hompes PG, for the IPD MARIA study group. Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Hum Reprod Update 2011; 17: 501-9.
5. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update 2008; 14: 623-45.
6. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, For GG. Evidence-based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 1369-73.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
8. Di Micco P, D'Uva M, Lodigiani C, Rota LL. Thrombophilia and repeated in vitro fertilisation and embryo transfer failure: an open issue. Thromb Haemost 2010; 103: 472-3.
9. Berker B, Taşkin S, Kahraman K, Taşkin EA, Atabekoǧlu C, Sönmezer M. The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. Fertil Steril 2011; 95: 2499-502.
10. Noci I, Milanini MN, Ruggiero M, Papini F, Fuzzi B, Artini PG. Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study. Reprod Biomed Online 2011; 22: 615-20.
11. Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod 2009; 24: 1640-7.
12. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb) 2008; 11: 246-53.
13. Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003; 80: 376-83.
14. Sher G, Zouves C, Feinman M, Maassarani G, Matzner W, Chong P, Ching W. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am J Reprod Immunol 1998; 39: 391-4.
15. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 1997; 12: 1171-5.
16. Lacey H, Haigh T, Westwood M, Aplin JD. Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2002; 24: 2.
17. Lodigiani C, Di Micco P, Ferrazzi P, Librè L, Arfuso V, Polatti F, Michela B, Rossini R, Morenghi E, Rota L, Brenner B, Paolo EL. Low-molecular-weight heparin in women with repeated implantation failure. Womens Health (Lond Engl) 2011; 7: 425-31.
18. Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril 2001; 76: 201-2.
19. Di Nisio M, Rutjes AW, Ferrante N, Tiboni GM, Cuccurullo F, Porreca E. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood 2011; 118: 2670-8.